Targeting BRD3 eradicates nuclear TYRO3-induced colorectal cancer metastasis
Science Advances · 2023
DOI: 10.1126/sciadv.ade3422 ↗At a glance
Journal article in Science Advances, 2023. Written by Pei-Ling Hsu and 8 co-authors. Institution: Department of Anatomy, School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung 80708, Taiwan. Major MEDLINE topics: Colorectal Neoplasms, Matrix Metalloproteinase 2. Cited 27 times so far (Crossref); 47 references. The full text is freely available in PubMed Central.
Abstract (original language)
Metastasis is the main cause of death in many cancers including colorectal cancer (CRC); however, the underlying mechanisms responsible for metastatic progression remain largely unknown. We found that nuclear TYRO3 receptor tyrosine kinase is a strong predictor of poor overall survival in patients with CRC. The metastasis-promoting function of nuclear TYRO3 requires its kinase activity and matrix metalloproteinase–2 (MMP-2)–mediated cleavage but is independent of ligand binding. Using proteomic analysis, we identified bromodomain-containing protein 3 (BRD3), an acetyl-lysine reading epigenetic regulator, as one of nuclear TYRO3’s substrates. Chromatin immunoprecipitation-sequencing data reveal that TYRO3-phosphorylated BRD3 regulates genes involved in anti-apoptosis and epithelial-mesenchymal transition. Inhibition of MMP-2 or BRD3 activity by selective inhibitors abrogates nuclear TYRO3-induced drug resistance and metastasis in organoid culture and in orthotopic mouse models. These data demonstrate that MMP-2/TYRO3/BRD3 axis promotes the metastasis of CRC, and blocking this signaling cascade is a promising approach to ameliorate CRC malignancy.
Subjects
MeSH terms (MEDLINE)
Substances
Authors and institutions
- Department of Anatomy, School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung 80708, Taiwan.
- Department of Medical Research, Kaohsiung Medical University Hospital, Kaohsiung 80708, Taiwan.
- Department of Physiology, College of Medicine, National Cheng Kung University, Tainan 70101, Taiwan.
- Institute of Molecular Medicine, College of Medicine, National Cheng Kung University, Tainan 70101, Taiwan.
- Division of Colorectal Surgery, Department of Surgery, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan 70101, Taiwan.
- Institute of Basic Medical Sciences, College of Medicine, National Cheng Kung University, Tainan 70101, Taiwan.
ORCID profiles: Pei-Ling Hsu, Yen-An Tang, Shih-Chieh Lin, Yi-Syuan Lin, H Sunny Sun, Shaw-Jenq Tsai
Cite
APA
Hsu, P. L., Chien, C. W., Tang, Y. A., Lin, B. W., Lin, S. C., Lin, Y. S., Chen, S. Y., Sun, H. S., & Tsai, S. J. (2023). Targeting BRD3 eradicates nuclear TYRO3-induced colorectal cancer metastasis. Science Advances. https://doi.org/10.1126/sciadv.ade3422
Vancouver
Hsu PL, Chien CW, Tang YA, Lin BW, Lin SC, Lin YS, et al. Targeting BRD3 eradicates nuclear TYRO3-induced colorectal cancer metastasis. Science Advances. 2023. doi:10.1126/sciadv.ade3422
BibTeX
@article{Hsu2023,
author = {Hsu, Pei-Ling and Chien, Chun-Wei and Tang, Yen-An and Lin, Bo-Wen and Lin, Shih-Chieh and Lin, Yi-Syuan and Chen, Sih-Yu and Sun, H Sunny and Tsai, Shaw-Jenq},
title = {Targeting BRD3 eradicates nuclear TYRO3-induced colorectal cancer metastasis},
journal = {Science Advances},
year = {2023},
doi = {10.1126/sciadv.ade3422}
}
EUVIMED